Â鶹´«Ã½É«ÇéƬ

is a professor at the Technical University of Denmark.  Her main research interests are structure/function relationships and applications of multidomain carbohydrate active enzymes acting on starch, alginate and other dietary polysaccharide fibers, proteins and hydrocolloids in food and dairy. Svensson has been a member of the JBC Editorial Board since 2014.

is a physician–scientist at Albert Einstein College of Medicine in New York City. His main interests include metabolism and cardiovascular medicine with a particular emphasis on translational discoveries. Research in his lab spans from non-coding RNAs to intracellular calcium, from mitochondrial dysfunction to oxidative stress, with applications to human health and clinical practice in fields including diabetes, cardiac disorders and aging. He is honored to be a part of a rigorous peer-review process that is both constructive and fair. He has been JBC Editorial Board member since 2019.

is a professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta. His research interests are focused on understanding transition metal and redox homeostasis and signaling. Reddi has served on the JBC Editorial Board since 2020 and has enjoyed reading and publishing in JBC his entire academic life.

is a John P. Long Endowed Professor of Neuroscience and Pharmacology and co-director of the Pain Research Program at the University of Iowa College of Medicine. His laboratory studies molecular and cellular mechanisms of nociception and pain processing. Another focus of his research program is investigation of mitochondrial dynamics and Ca2+ transport in the regulation of neuronal function in health and disease. He has been on the JBC Editorial Board since 2015 and always enjoyed working with an outstanding team of editors who strive to provide rigorous and fair peer-review process at every level.

investigates the biology of lipid oxidation products with a focus on endothelial and epithelial dysfunction during sepsis and in response to environmental inhalation injury. He is a physiologist who gets excited about new lipid discoveries and understanding the role of new lipid molecules in disease.

is an expert in the interpretation of tandem mass spectrometry spectra of peptides, including de novo sequencing as well as the characterization of covalently modified molecules, especially O-linked glycopeptides. She has served as an ad hoc reviewer for several journals and is on the editorial board of Biomolecules. In 2015, she retired from the Mass Spectrometry Facility of the University of California, San Francisco, but remains affiliated with the pharmaceutical chemistry department as an adjunct professor. She is also a consultant for the Laboratory of Proteomics Research of the HUN-REN Biological Research Centre in Szeged, Hungary, where she was the group leader until 2021. She has been on the MCP board since 2004.

leads the Integrative Cell Signaling and Proteomics Group within the haemato-oncology department at Barts Cancer Institute. He is a fellow of the Turing Institute and has worked in liquid chromatography–tandem mass spectometry proteomics for 20 years. His research group uses unique proteomics and computational approaches to understand how cell signaling pathways driven by the activity of protein kinases contribute to the development of cancer.

is a professor at St. Jude Children’s Research Hospital, where he develops mass spectrometry–based proteomics, metabolomics and systems biology approaches to tackle biomedical challenges. He has contributed to the establishment of target–decoy strategies for protein and metabolite identification, the discovery of ubiquitin code and the identification of RNA splicing dysfunction and other novel disease-related proteins in Alzheimer’s disease. He has published over 250 scientific papers and trained approximately 100 group members. He has served as an ad hoc reviewer for more than 80 scientific journals and has been on the MCP Editorial Board since 2015.